Functional diversity of macrophages in vascular biology and disease
- PMID: 29074468
- DOI: 10.1016/j.vph.2017.10.005
Functional diversity of macrophages in vascular biology and disease
Abstract
Atherosclerosis is a multifactorial chronic inflammatory disease and is largely responsible for cardiovascular disease, the most common cause of global mortality. The hallmark of atherogenesis is immune activation following lipid accumulation in the arterial wall. In particular, macrophages play a non-redundant role in both the progression and regression of inflammation in the atherosclerotic lesion. Macrophages are remarkably heterogeneous phagocytes that perform versatile functions in health and disease. Their functional diversity in vascular biology is only partially mapped. Targeting macrophages is often highlighted as a therapeutic approach for cancer, metabolic and inflammatory diseases. Future strategies for therapeutic intervention in atherosclerosis may benefit from attempts to reduce local proliferation of pro-inflammatory macrophage subsets or enhance resolution of inflammation. Thus, characterisation of macrophage subsets during atherosclerosis would empower clinical interventions. Therefore, it would be of fundamental importance to understand how pathological factors modulate macrophage activity in order to exploit their use in the treatment of atherosclerosis and other diseases.
Keywords: Arterial macrophages; Atherosclerosis; Macrophage subsets; Macrophages; Transcription factors.
Copyright © 2017 Elsevier Inc. All rights reserved.
Similar articles
-
Macrophages and dendritic cells: the usual suspects in atherogenesis.Curr Drug Targets. 2015;16(4):373-82. doi: 10.2174/1389450116666150330115809. Curr Drug Targets. 2015. PMID: 25808566 Review.
-
Differentiation factors and cytokines in the atherosclerotic plaque micro-environment as a trigger for macrophage polarisation.Thromb Haemost. 2011 Nov;106(5):763-71. doi: 10.1160/TH11-05-0320. Epub 2011 Sep 22. Thromb Haemost. 2011. PMID: 21947328 Review.
-
Atherosclerosis and immunity: A perspective.Trends Cardiovasc Med. 2019 Aug;29(6):363-371. doi: 10.1016/j.tcm.2018.09.017. Epub 2018 Sep 28. Trends Cardiovasc Med. 2019. PMID: 30292470 Review.
-
Macrophage Phenotype and Function in Different Stages of Atherosclerosis.Circ Res. 2016 Feb 19;118(4):653-67. doi: 10.1161/CIRCRESAHA.115.306256. Circ Res. 2016. PMID: 26892964 Free PMC article. Review.
-
Cytokines, macrophage lipid metabolism and foam cells: implications for cardiovascular disease therapy.Prog Lipid Res. 2011 Oct;50(4):331-47. doi: 10.1016/j.plipres.2011.04.002. Epub 2011 May 13. Prog Lipid Res. 2011. PMID: 21601592 Review.
Cited by
-
Macrophage-Targeted Therapeutics for Metabolic Disease.Trends Pharmacol Sci. 2018 Jun;39(6):536-546. doi: 10.1016/j.tips.2018.03.001. Epub 2018 Apr 5. Trends Pharmacol Sci. 2018. PMID: 29628274 Free PMC article. Review.
-
Age-Related Changes in Immune Cells of the Human Cochlea.Front Neurol. 2019 Aug 16;10:895. doi: 10.3389/fneur.2019.00895. eCollection 2019. Front Neurol. 2019. PMID: 31474935 Free PMC article.
-
M2 Macrophage-Derived Exosomes Inhibit Apoptosis of HUVEC Cell through Regulating miR-221-3p Expression.Biomed Res Int. 2022 Sep 7;2022:1609244. doi: 10.1155/2022/1609244. eCollection 2022. Biomed Res Int. 2022. PMID: 36119928 Free PMC article.
-
Syncytium calcium signaling and macrophage function in the heart.Cell Biosci. 2018 Mar 27;8:24. doi: 10.1186/s13578-018-0222-6. eCollection 2018. Cell Biosci. 2018. PMID: 29599964 Free PMC article. Review.
-
Development of a CD163-Targeted PET Radiotracer That Images Resident Macrophages in Atherosclerosis.J Nucl Med. 2024 May 1;65(5):775-780. doi: 10.2967/jnumed.123.266910. J Nucl Med. 2024. PMID: 38548349 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical